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Introduction
Huntington’s disease (HD) is a neurodegenerative disorder 
caused by expansion of the CAG repeat in the gene encoding 
Huntingtin (Htt), which confers to the protein an expanded 
NH2-terminal polyglutamine (polyQ) stretch of >35 residues 
(for review see Harjes and Wanker, 2003). The function of Htt 
is largely unclear. It has been shown to interact with microtu-
bules (Hoffner et al., 2002) and to display anti-apoptotic activ-
ity (Rigamonti et al., 2000, 2001). Insights into its function 
came from studies of Htt-interacting proteins (HIPs) and Htt-
  associated proteins (HAPs). For example, interactions with 
HIP1, HIP1R, PACSIN1, SH3GL3, and HIP14 have implicated 
Htt in clathrin-mediated endocytosis. Studies of HAP1 have 
suggested a role for Htt in axonal transport in neurons by link-
ing vesicles to the dynein–dynactin motor complex (Block-
Galarza et al., 1997; Engelender et al., 1997). The polyQ 
expansion confers the adjacent proline-rich sequence in Htt 
  alterations in binding affi   nity to HIPs/HAPs. Thus, release 
from  or sequestration of these molecules by mutant Htt has 
been implicated in the pathogenetic mechanisms.
For example, the tighter binding of HAP1 to mutant Htt is 
thought to impair the correct dynactin–dynein motor complex 
assembly and cause a traffi  cking defect, leading to neuronal de-
generation (Block-Galarza et al., 1997; Engelender et al., 1997; 
Gauthier et al., 2004). Consistently, mutant Htt was recently 
shown to release dynein from microtubules and reduce the mo-
tility of EGFP  –brain-derived neurotrophic factor–containing 
vesicles in vivo (Gauthier et al., 2004). However, the upstream 
events that target Htt and its partners to their various sites of 
function and the mechanisms whereby they regulate intracellu-
lar traffi  cking remain elusive.
In this study, we report an unexpected link between Htt 
and the small GTPase Rab5 via the adaptor protein HAP40. 
Rab5 is a key regulator of endocytosis that orchestrates the 
  recruitment of multiple effector proteins on the early endo-
some membrane to regulate organelle tethering, fusion, and 
  microtubule-dependent motility (Zerial and McBride, 2001). 
Our data extend the analysis of the Rab5 effector machinery by 
functionally implicating the interaction between Rab5 and Htt 
in the regulation of the differential association of early endo-
somes with the actin and tubulin cytoskeleton.
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T
he molecular mechanisms underlying the targeting 
of Huntingtin (Htt) to endosomes and its multifaceted 
role in endocytosis are poorly understood. In this 
study, we have identiﬁ  ed Htt-associated protein 40 (HAP40) 
as a novel effector of the small guanosine triphosphatase 
Rab5, a key regulator of endocytosis. HAP40 mediates 
the recruitment of Htt by Rab5 onto early endosomes. 
HAP40 overexpression caused a drastic reduction of early 
endosomal motility through their displacement from mi-
crotubules and preferential association with actin ﬁ  laments. 
Remarkably, endogenous HAP40 was up-  regulated in ﬁ  -
broblasts and brain tissue from human patients affected 
by Huntington’s disease (HD) as well as in STHdhQ
111 
  striatal cells established from a HD mouse model. These 
cells   consistently displayed altered endosome motility and 
endocytic activity, which was restored by the ablation of 
HAP40. In revealing an unexpected link between Rab5, 
HAP40, and Htt, we uncovered a new mechanism regu-
lating cytoskeleton-dependent endosome dynamics and 
its dysfunction   under pathological conditions.JCB • VOLUME 172 • NUMBER 4 • 2006  606
Results
The Htt–HAP40 complex is a novel 
Rab5 effector
Affi  nity chromatography revealed several downstream effectors 
of the small GTPase Rab5 (Christoforidis et al. 1999). Surpris-
ingly, among the proteins specifi  cally eluted from the GST-
Rab5–GTPγS but not from the Rab5–guanosine diphosphate 
(GDP) nor GST-Rab4 affi  nity column, we identifi  ed Htt and 
HAP40 (Peters and Ross, 2001) by mass spectrometry and im-
munoblotting (Fig. 1, A and B). Therefore, we investigated the 
function of HAP40 and Htt with respect to Rab5.
We fi  rst tested whether HAP40, Htt, or both interact 
directly and specifi  cally with Rab5. To this end, full-length 
HAP40 was cloned from a rat brain cDNA library and in vitro 
translated. Because of its large molecular mass (348 kD; Fig. 
2 A), fragments of wild-type Htt were translated to facilitate 
the analysis. In vitro translation yielded major products of pre-
dicted size as well as lower molecular mass bands presumably 
as a result of internal initiation (Fig. 2 B). Immobilized Rab5-
GST fusion protein preloaded with either GDP or GTPγS were 
incubated with the translation products and washed, and bound 
proteins were eluted with glutathione analyzed by SDS-PAGE 
and autoradiography (Christoforidis et al., 1999). Similar to 
early endosome antigen 1 (EEA1), which served as a positive 
control, HAP40 displayed specifi  c binding to GTPγS- versus 
GDP-bound Rab5 (Fig. 2 C, compare lanes 1 and 11 with lanes 
2 and 12). In contrast, none of the Htt fragments exhibited sig-
nifi  cant binding to Rab5 (Fig. 2 C, lanes 3–10). Because Htt 
was purifi  ed on the GST-Rab5 affi  nity column, we next tested 
whether binding of Htt to Rab5 occurs indirectly and requires 
HAP40 as a bridge. HAP40 and Htt fragments were cotranslated 
in vitro (Fig. 2 B, lanes 6–9) and applied on the Rab5 columns. 
Indeed, the COOH-terminal part of Htt (Fig. 2 A, Htt4) was 
eluted together with HAP40 from GTPγS- but not GDP-bound 
GST-Rab5 (Fig. 2 D, lanes 7 and 8). None of the other Htt frag-
ments displayed such binding (Fig. 2 D, lanes 1–6), which is 
consistent with the reported interaction map between HAP40 
and Htt (Peters and Ross, 2001). Neither the Htt fragments nor 
HAP40 displayed binding to Rab4, Rab6, Rab7, or Rab11 (Fig. 
2 D), suggesting the interaction with Rab5 is specifi  c. Thus, we 
conclude that HAP40 binds to the COOH-terminal part of Htt 
and links the complex to active Rab5. By applying a 10-fold 
excess of the COOH-terminal fragment of Htt onto the Rab5 
column to reduce binding of free HAP40 to Rab5 (Fig. 2 E), we 
estimated the stoichiometry of the Rab5/HAP40/Htt interaction 
in this assay to be  1:1:1 (see Rab5 affi  nity…cloning).
Htt is recruited onto early endosome 
in a HAP40- and Rab5-dependent manner
We began testing the functional relevance of this interaction 
in vivo by immunofl  uorescence microscopy analysis of HeLa 
cells. First, we verifi  ed that the anti-HAP40 antibody resulted 
in specifi  c staining above background levels for detection of 
the endogenous antigen (Fig. 3 A). Endogenous HAP40 dis-
played a diffuse staining in the cytoplasm and accumulated 
in the nucleus, whereas endogenous Htt localized to discrete 
  cytoplasmic structures (Fig. 3 B) as reported previously (Peters 
and Ross, 2001; Tao and Tartakoff, 2001). Colocalization of 
endogenous HAP40 and Htt was hardly detectable (Fig. 3 B).
Early endosomes labeled with EGFP-Rab5 displayed little co-
localization with endogenous Htt (7 ± 5% overlap; n = 10; 
Fig. 3 C). However, the association of HAP40 with early en-
dosomes dramatically increased upon overexpression. In cells 
overexpressing HAP40 (see Fig. 7 D) but not EGFP-Rab5 
alone, HAP40 signifi  cantly colocalized with endogenous Htt on 
EGFP-Rab5–positive early endosomes (Fig. 3, compare B with 
D; endogenous Htt and EGFP-Rab5: 43 ± 6% overlap, n = 10;
HAP40 and EGFP-Rab5: 31 ± 7% overlap, n = 10; Fig. 3, 
compare C with D). We experimentally verifi  ed that the HAP40 
fl   uorescence signals (Fig. 3 D) were not caused by bleed-
through of the Htt signals (because of extended AlexaFluor568 
emission in the Cy5 channel) and that swapping these fl  uores-
cent dyes on the secondary antibodies resulted in similar distri-
bution patterns of Htt and HAP40 (see Cell culture   procedures). 
The endosomal colocalization of endogenous HAP40 and 
Htt was even more striking upon expression of the activated 
EGFP-Rab5Q79L mutant (Htt: 52 ± 7% overlap, n  = 8),
which caused the characteristic swelling of early endosomes 
(Fig. 4 A; Stenmark et al., 1994). 
Given the diffi  culties detecting endogenous HAP40 and 
Htt on early endosomes in untreated cells (Fig. 3, B and C) we 
sought to verify the changes in the localization of both proteins 
upon the overexpression of HAP40 biochemically. To this end, 
we prepared early endosomes from HeLa cells for Western blot 
analysis. Indeed, we found that the levels of HAP40 and Htt in-
creased on early endosomes from the HAP40 overexpressor 
compared with untreated cells (Fig. 3 E). Early endosome 
(EEA1 and transferrin receptor [Tfr]) as well as lysosomal 
  (lysosome-associated membrane protein (LAMP); Eskelinen 
et al., 2003) and Golgi (GM130; Nakamura et al., 1995) markers 
Figure 1.  Htt and HAP40 elute from immobilized Rab5. (A) SDS-PAGE of 
proteins eluted from immobilized GST-Rab5 that was loaded with GTPγS. 
The indicated bands were found to correspond to Htt, HAP40, Rab5-GST, 
and EEA1 by mass spectrometry analysis. (B) Western blot analysis of 
chromatographic eluates from GST-Rab5 (lanes 1 and 2) and -Rab4 (lanes 3 
and 4) afﬁ  nity columns preloaded with GDP (D; lanes 1 and 3) or GTPγS 
(T; lanes 2 and 4). The bovine brain cytosol (BBC; lane 5) was used as a 
source of proteins. Blots were probed for Htt and HAP40 as indicated.THE HTT–HAP40 COMPLEX IS A NOVEL RAB5 EFFECTOR • PAL ET AL. 607
remained unchanged, confi  rming equal loading and the speci-
fi  city of changes through elevated HAP40 on early endosomes.
To confi  rm the requirement of HAP40 for the recruitment 
of Htt onto early endosomes, we transfected HeLa cells with 
short interfering RNA (siRNA) duplexes against HAP40 and un-
related siRNA (against GFP) as control. The HAP40 siRNA spe-
cifi  cally and effi  ciently reduced the protein levels by  90% (Fig. 
4 C), whereas the level of EEA1 remained unchanged. When 
cells were cotransfected with the expression vector for EGFP-
Rab5Q79L and HAP40 siRNA, Htt was no longer detectable on 
the enlarged endosomes (8 ± 6% overlap, n = 9; Fig. 4 B), con-
fi  rming HAP40 as a prerequisite to bridge Htt to active Rab5. 
Collectively, these data suggest that active Rab5 and HAP40 are 
rate limiting for the recruitment of Htt onto early endosomes.
The Htt–HAP40 complex inhibits 
the binding and motility of early endosomes 
on microtubules
Htt has previously been shown to bind microtubules and reg-
ulate microtubule–motor interactions (Block-Galarza et al., 
1997; Engelender et al., 1997; Hoffner et al., 2002; Gauthier 
et al., 2004). Because Rab5 regulates endosome motility along 
microtubules (Nielsen et al., 1999; Hoepfner et al., 2005), we 
explored the role of the Htt–HAP40 complex in this process. 
First, by using a cell- and cytosol-free assay that recapitulates 
the Rab5-dependent movement of early endosomes along mi-
crotubules (Hoepfner et al., 2005), we found that Htt–HAP40 
inhibited microtubule-dependent early endosome motility. 
  Addition of the GTPγS- (containing Htt and HAP40; Fig. 1 B) 
but not the GDP-loaded Rab5 column eluate reduced the motility 
 compared with control conditions (Fig. 5 A). This inhibition was 
Figure 2.  Htt–HAP40 complex is a novel Rab5 effector. (A) Schematic 23 
glutamine residues (23Q), the adjacent proline-rich sequence (P), the 
  caspase-3 cleavage site, and the four recombinant fragments (Htt1–4) 
cloned in pcDNA3.1 using the indicated restriction sites. (B) Autoradio-
graph of in vitro–translated Htt fragments (Htt1–4) and HAP40. Full-length 
HAP40 cDNA and Htt fragments were in vitro translated in the presence of 
[
35S]methionine, separated by SDS-PAGE, and autoradiographed. Given 
their large size, the bands of strongest intensity (arrows) and correspond-
ing to the predicted masses for HAP40 ( 40 kD, lane 1), Htt1 ( 65 kD, 
lane 2), Htt2 ( 97 kD, lane 3), Htt3 ( 84 kD, lane 4), and Htt4 ( 102 kD, 
lane 5) were accompanied by multiple products because of either initiation 
of translation at internal sites or premature termination. Lanes 6–9: each 
Htt fragment was cotranslated with HAP40. (C) Autoradiograph of the in 
vitro–translated proteins in B eluted from immobilized GST-Rab5 preloaded 
with GTPγS (T) or GDP (D). (D) Autoradiograph of Htt fragments cotrans-
lated in vitro with HAP40 and eluted from various immobilized Rab pro-
teins as indicated. The experiment was performed as described in C, but 
Htt fragments and HAP40 were cotranslated (see B, lanes 6–9) and ap-
plied onto immobilized Rab proteins. Besides HAP40, the COOH-terminal 
Htt fragment (Htt4) was eluted from GST-Rab5 beads (compare lanes 7 
with 8), whereas Htt1 (lanes 1 and 2), Htt2 (lanes 3 and 4), and Htt3 
(lanes 5 and 6) did not show signiﬁ  cant speciﬁ  c association with Rab5. 
Moreover, none of the Htt fragments or HAP40 displayed speciﬁ  c interac-
tions with GST-Rab4, 6, 7, or 11. Positive controls (POS, lanes 9 and 10) for 
each Rab protein were EEA1 ( 170 kD) for Rab5, Rabenosyn-5 ( 89 kD) 
for Rab4 (de Renzis et al., 2002), VPS39 ( 100 kD) for Rab7 (Rink et al., 
2005), and GapCenA ( 115 kD) for Rab6 and 11 (Cuif et al., 1999 and 
unpublished data). (E) Htt and HAP40 elute in equimolar amounts from the 
Rab5 column. A mixture of Htt4 and HAP40 was applied onto Rab5 
  columns and eluted as in D but with a 10-fold excess of Htt4 to prevent 
HAP40 from binding freely to Rab5. (C–E) Arrows point to correct transla-
tion products as in B.JCB • VOLUME 172 • NUMBER 4 • 2006  608
specifi  cally rescued with anti-Htt but not unrelated antibodies. 
The addition of 1 μM GST-HAP40 fusion protein completely 
blocked the in vitro motility (Fig. 5, A and B). Second, we   
performed a biochemical early endosome–microtubule-  binding 
assay as described previously (Nielsen et al., 1999) with 
some modifi  cations to improve the quantitative assessment. 
An early endosome–enriched fraction was prepared from 
HeLa cells pulsed with rhodamine–transferrin, incubated with 
Figure 3.  Overexpressed HAP40 recruits Htt onto early 
  endosomes. Immunoﬂ  uorescence microscopy analysis of HeLa 
cells expressing EGFP-Rab5 and/or HAP40 and immuno-
stained for HAP40 and Htt as indicated. (A) The anti-HAP40 
antibody speciﬁ   cally recognizes its antigen (green). Cells 
were stained with the antibody alone (anti-HAP40) or pre-
mixed with HAP40-GST fusion (anti-HAP40 & GST-HAP40) or 
GST protein (anti-HAP40 & GST). The image after speciﬁ  c de-
pletion of the antibody (anti-HAP40 & GST-HAP40) was ob-
tained at sixfold prolonged exposure time compared with the 
others. (B) Endogenous Htt (red) and endogenous HAP40 
(green); <1% overlapping (n = 10). (C) Endogenous Htt (red) 
and EGFP-Rab5 (green); 7% overlapping (SD ± 5%, n = 10). 
(D) Overexpressed HAP40 (red) recruits endogenous Htt (red) 
onto endosomes labeled with EGFP-Rab5WT (green); 43% 
overlapping of endogenous Htt with EGFP-Rab5 (merge Rab5 & 
Htt; SD ± 6%, n = 10) and 31% overlapping of overex-
pressed HAP40 with EGFP-Rab5 (merge Rab5 & HAP40; 
SD ± 7%, n = 10). Cells were cotransfected with HAP40 and 
GFP-Rab5WT expression constructs. Arrowheads in insets 
(magniﬁ  ed images of boxed areas) highlight colocalization. 
Bar, 10 μm. (E) Western blot analysis of early endosomes 
prepared from untreated (WT) or HeLa cells overexpressing 
HAP40 (HAP40). Blots were probed for HAP40, Htt, EEA1, 
transferrin receptor (Tfr), LAMP1, and GM130 as indicated.THE HTT–HAP40 COMPLEX IS A NOVEL RAB5 EFFECTOR • PAL ET AL. 609
taxol-  stabilized microtubules, ATP, and factors to be tested, 
and centrifuged through a sucrose cushion. The resulting pellet 
of microtubule-associated material was analyzed by immuno-
blotting (Fig. 6 A) and fl  uorimetrically for the rhodamine–
 transferrin  content (Fig. 6 D). In a dilution series for calibration, 
we verifi  ed that the amount of endosomes and fl  uorescence in-
tensity correlated linearly (see Microtubule and actin spin-down 
 assays). Western blotting revealed that the β-tubulin content was 
similar between samples, ruling out secondary effects on micro-
tubule stability (Fig. 6 A, compare lanes 2–5 with lane 1). The 
addition of 1 μM GST-HAP40 protein decreased the amount 
of early endosomes in the pellet as revealed by EEA1 and Tfr 
(Fig. 6 A, compare lane 3 with lane 2). The GST-Rab5–GTPγS 
  column eluate adding  0.3 μM HAP40 (Fig. 6 C) caused a 
similar   inhibition (Fig. 6A, compare lane 4 with lane 2) that was 
rescued through the addition of antiserum against Htt (Fig. 6 A, 
compare lane 5 with lanes 4 and 2). To rule out the idea that the 
observed differences result from the bundling of microtubules 
causing unspecifi  c cosedimentation of any membranous struc-
ture, we probed the pellets for nonendosomal contaminants in 
the fraction. Both the lysosomal (LAMP1) and Golgi marker 
(GM130) pelleted with similar effi  ciency in all samples. Collec-
tively, these data indicate that Htt–HAP40 specifi  cally lowers 
the binding of early endosomes to microtubules.
Having validated the assay, we next quantifi  ed the amount 
of endosomes bound to microtubules fl  uorimetrically. Omission 
of either microtubules or early endosomes reduced the fl  uores-
cence signal to background levels (Fig. 6 D). As reported previ-
ously (Nielsen et al., 1999), the association of early endosomes 
with microtubules was energy dependent and required active 
Rab5. Omitting ATP or substituting it with the nonhydrolyzable 
adenylyl-imidodiphosphate analogue resulted in an  50% 
Figure 4.  Htt is recruited onto early endo-
somes in a Rab5- and HAP40-dependent 
  fashion. Immunoﬂ  uorescence microscopy anal-
ysis of HeLa cells transfected with expression 
vectors for EGFP-Rab5Q79L alone or cotrans-
fected with siRNA duplexes against HAP40 as 
indicated. (A) EGFP-Rab5Q79L (green) recruits 
endogenous Htt (red) onto endosomes; 52% 
overlapping (SD ± 7%, n = 8). Cells were 
transfected with EGFP-Rab5Q79L expression 
construct alone. (B) RNAi against HAP40 
  (siHAP40) leads to the loss of endogenous 
Htt (red) from endosomes; 8% overlapping 
(SD ± 6%, n = 9). Cells were cotransfected 
with HAP40 siRNA and EGFP-Rab5Q79L 
(green) expression constructs. Bar, 10 μm. 
(C) Knockdown of HAP40 protein by RNAi as 
shown by Western blot analysis. EEA1 and 
HAP40 expression levels in untransfected cells 
(control) and cells transfected with unrelated 
(siGFP) or siRNA against HAP40 (siHAP40).JCB • VOLUME 172 • NUMBER 4 • 2006  610
  reduction in microtubule binding. The requirement for ATP can 
be explained by the role of PI3-K in the assembly and mainte-
nance of a functional Rab5 domain on endosomes (Zerial and 
McBride, 2001) and in recruitment of the endosomal kinesin 
KIF16B (Hoepfner et al., 2005). Extraction of Rab proteins 
from membranes by the addition of 1 μM of recombinant 
Rab–GDP dissociation inhibitor (GDI; Ullrich et al., 1994) or 
treatment with RN-tre, a GTPase-activating protein for Rab5 
(Lanzetti et al., 2000), caused an  40% reduction of endosomes 
in the pellet (Fig. 6 D). As for endosome motility (Fig. 5 A), 
Htt and HAP40 inhibited endosome–microtubule binding. 
The GST-Rab5–GTPγS column eluate led to an  25% reduc-
tion in binding (Fig. 6 D), but supplementing the reaction 
with antibodies against Htt restored binding to control levels. 
The addition of 1 μM HAP40-GST fusion protein decreased the 
binding by  60%, whereas GST alone did not have any effect. 
Collectively, these data underpin the ability of HAP40 and Htt 
to destabilize endosome–microtubule association.
We next performed time-lapse video microscopy studies 
to correlate these biochemical fi  ndings in vitro with the regula-
tion of early endosome dynamics in vivo. We detected a dras-
tic reduction in motility of EGFP-Rab5–positive endosomes in 
HeLa cells overexpressing HAP40 (Fig. 7 A) compared with 
cells transfected with EGFP-Rab5 alone (Fig. 7 A and Vid-
eos 1 and 2, available at http://www.jcb.org/cgi/content/full/
jcb.200509091/DC1). Whereas some residual motility activ-
ity was observed in the cell periphery, early endosomes in the 
perinuclear region appeared static, with frequent short-range 
movements almost completely impaired in long-range motility 
(Nielsen et al., 1999, Rink et al. 2005). Collectively, these data 
suggest that the Rab5-dependent recruitment of Htt onto endo-
somes by HAP40 disrupts early endosome–microtubule inter-
actions, thus leading to a reduction in organelle motility.
HD cells display increased levels of HAP40 
and are impaired in early endosome motility
We next asked whether alterations of endosome motility could 
occur in cells bearing the HD mutation. Primary fi  broblasts 
from fi  ve healthy individuals and fi  ve unrelated HD patients 
were transfected with EGFP-Rab5 to compare the motility of 
early endosomes. The identity of the HD cell lines was con-
fi  rmed by Western blotting to detect the polyQ-expanded Htt. 
Because the cells were derived from patients heterozygous for 
the HD gene, they express both normal and mutant Htt. 
The latter is known to display a lower mobility in SDS-PAGE 
(Trottier et al., 1995), thus causing a doublet on the blot (Fig. 7 D). 
Strikingly, we observed a severe reduction in early endosome 
motility in all HD cell lines compared with fi  broblasts from 
healthy individuals (Fig. 7 B and Videos 3 and 4, available 
at http://www.jcb.org/cgi/content/full/jcb.200509091/DC1). 
The   similarity between this phenotype and the alterations in-
duced upon HAP40 overexpression in HeLa cells (Fig. 7 A and 
Videos 1 and 2) hinted to a common molecular basis. Interest-
ingly, we discovered an  10-fold up-regulation of endogenous 
HAP40 levels by Western blotting in all HD cell lines com-
pared with normal fi  broblasts (Fig. 7 D). As a control, the lev-
els of EEA1 remained unchanged. Moreover, we found that 
Figure 5.  Htt and HAP40 decrease in vitro reconstituted motility of early 
endosomes along microtubules. (A) Puriﬁ  ed early endosomes labeled by 
internalization of rhodamine–transferrin were mixed with buffer (control) 
alone or with various eluates of bovine brain cytosol proteins that were af-
ﬁ  nity puriﬁ  ed on GST-Rab5 columns. Eluate obtained from columns loaded 
with GDP was added directly to the sample (+GDP-eluate). Eluate ob-
tained from columns loaded with GTPγS was added directly to the sample 
(+GTP-eluate) or after preincubation with antiserum against the cytoplas-
mic domain of Tfr (+eluate + anti-Tfr), antiserum against Htt (+eluate 
+ anti-Htt), or without eluate but with 1 μM of recombinant GST-HAP40 fu-
sion protein (+HAP40). In vitro motility of early endosomes along micro-
tubules recorded using time-lapse ﬂ   uorescence video microscopy (see 
Materials and methods) was quantiﬁ   ed by counting motility events per 
video. Error bars show the SD of 10 videos. (B) Videos recorded under 
control conditions (control) or with 1 μM GST-HAP40 fusion protein 
(HAP40) used for the analysis in A are displayed as merged stacks of over-
laid images collected at 2-s intervals over 2 min. When represented in this 
manner, a moving object will generate a trajectory consisting of a linear 
series of overlapping spots. Bar, 10 μm.THE HTT–HAP40 COMPLEX IS A NOVEL RAB5 EFFECTOR • PAL ET AL. 611
HAP40 protein levels were signifi  cantly elevated in striatal tissue 
(caudate, putamen, accumbens, and globus pallidus) from hu-
man postmortem brains affected by HD (adult onset grade) 
compared with control brains (Fig. 8 B). Our data suggest that 
the motility block in HD cells may be caused by elevated 
HAP40 levels, as mimicked by overexpression of HAP40 in 
HeLa cells. Consistently, endogenous Htt localized to EGFP-
Rab5–labeled endosomes in fi  broblasts from human HD pa-
tients as well as striatal STHdhQ cells from a HD mouse model 
(Trettel et al., 2000) but not in cells lacking the mutant Htt 
(Fig.  9). This phenotype is also caused by overexpressed 
HAP40 in HeLa cells (Fig. 3 D).
Our data do not exclude the possibility that the observed 
inhibition of early endosome motility may have other under-
lying causes. As a test to our hypothesis, we attempted to rescue 
the inhibition of early endosome motility by specifi  cally ab-
lating HAP40 from the HD fi  broblasts by RNA interference 
(RNAi). Transfection of HAP40 siRNA effi  ciently reduced the 
HAP40 protein levels in these cells (Fig. 7 E) as in HeLa cells 
(Fig. 4 C). Indeed, endosome motility was restored by RNAi 
against HAP40 (Fig. 7 C and Video 5, available at http://www.
jcb.org/cgi/content/full/jcb.200509091/DC1) but not against 
GFP, suggesting that the up-regulation of HAP40 is indeed the 
underlying mechanism of the motility defect in HD fi  broblasts.
Given the ability of HAP40 to reduce endosome– microtubule 
binding in vitro (Fig. 6, A and D), we investigated whether the 
observed motility block in HD cell lines was caused by a release 
of endosomes from microtubules in vivo. Immunofl  uorescence 
analysis on cells transfected with EGFP-Rab5 showed a consid-
erable alignment of early endosomes to microtubules in healthy 
fi  broblasts (82 ± 9% overlap, n = 10) but to a much lesser 
 extent in HD cell lines (15 ± 6% overlap, n = 9; Fig. 7,  compare 
F with G). In contrast, early endosomes were strikingly aligned 
with fi   lamentous actin (F-actin) in all fi   ve HD cell lines 
(44 ± 8% overlap, n  = 10) but not in healthy fi  broblasts 
(2 ± 1% overlap, n = 10; Fig.7, compare G with F). A similar 
Figure 6.  Modulation of binding of early endosomes to microtubules and 
F-actin by Htt and HAP40. (A) Reduction of binding of early endosomes 
(EE) to microtubules in vitro caused by Htt and HAP40. A spin-down assay 
was performed (see Materials and methods), and the resulting pellet of mi-
crotubule-associated material was analyzed by immunoblotting with anti-
bodies against proteins indicated on the right. (B) Stimulation of binding of 
early endosomes to F-actin in vitro caused by Htt and HAP40. A spin-down 
assay was performed as described for A but with 10 μg of freshly polymer-
ized F-actin replacing the microtubule. (A and B) Microtubules (A) or F-actin 
(B) spun alone (−EE, lane 1), with early endosomes (control; +EE, lane 2), 
with early endosomes and 1 μM GST-HAP40 fusion protein (+EE+HAP40, 
lane 3), with early endosomes and 10 μg GST-Rab5–GTPγS column elu-
ate (+EE+eluate, lane 4), or eluate preincubated with anti-Htt antiserum 
(+EE+eluate+anti-Htt, lane 5). (C) Comparison of HAP40 protein levels 
in samples prepared for the early endosome–  microtubule/actin-binding 
assays. Samples were prepared as described for A and B either with GST-
HAP40 fusion (lane 1) or GST-Rab5–GTPγS column eluate (lane 2). 10-μl 
aliquots of each sample were separated by SDS-PAGE and immunoblotted 
for HAP40. Bands corresponded to the correct masses of GST-HAP40 or 
HAP40 as indicated on the right. Nonrelevant lanes on the same blot were 
sliced out in Adobe Photoshop to juxtapose the lanes shown. (D) Quantiﬁ  -
cations of early endosomes bound to microtubules. Binding was performed 
as described for A, but the resulting pellet of microtubule-  associated mate-
rial was lysed to release the rhodamine–transferrin label of early endo-
some. Fluorescence (arbitrary units) served as a direct measure for the 
amount of early endosomes bound to microtubules. Error bars represent 
the SD of samples in triplicate. Binding was performed in the presence 
of 15 μg of early endosomes and 16 μg of microtubules (control), in 
the absence of microtubules (−MT), in the absence of early endosomes 
(−EE), in the absence of ATP (−ATP), with all three components omitted 
(buffer), with 2 mM adenylyl-imidodiphosphate (+AMP-PNP), with 1 μM 
of recombinant RN-tre (+RN-tre), with 1 μM Rab-GDI (+GDI), with 1 μM 
HAP40-GST fusion protein (+HAP40), with 1 μM GST (+GST), with 10 μg 
GST-Rab5–GTPγS column eluate (+eluate), or with eluate preincubated 
with anti-Htt antiserum (+eluate+anti-Htt). (E) Quantiﬁ  cations of early en-
dosomes bound to F-actin. Binding was performed as described for B, and 
quantiﬁ  cations were made as in D. Binding was performed in the presence 
of 15 μg of early endosomes, 10 μg of F-actin (control), and with the 
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Figure 7.  Elevated protein levels of HAP40 shift early endosomes from microtubules to actin ﬁ  laments, causing a severe decrease of motility in vivo. HeLa 
cells and human primary ﬁ  broblasts expressing EGFP-Rab5 were imaged using time-lapse video microscopy. (A–C) Images generated by merging a stack 
of overlaid images collected at 300-ms intervals over 2 min, as for Fig. 5 B. Videos corresponding to A–C are available as online supplemental materials 
(Videos 1–5, available at http://www.jcb.org/cgi/content/full/jcb.200509091/DC1). (A) In HeLa cells, coexpression of EGFP-Rab5 and HAP40 (right) 
led to a drastic reduction in endosome motility compared with EGFP-Rab5 alone (WT, left). (B) In ﬁ  broblasts from HD patients (HD), such reduction was also 
evident from the comparison with ﬁ  broblasts from healthy individuals (WT). (C) RNAi against HAP40 in these HD ﬁ  broblasts (HAP40 RNAi) restores endo-
some motility. HD ﬁ  broblast cell lines were cotransfected with EGFP-Rab5 expression vector and siRNA against HAP40. (D) Similar to HeLa cells overex-
pressing HAP40 (compare lane 1 with lane 2), endogenous protein levels of HAP40 were elevated in ﬁ  ve HD ﬁ  broblast cell lines (lanes 8–12) compared 
with ﬁ  broblasts from ﬁ  ve healthy individuals (lanes 3–7). Blots were also probed with anti-EEA1 and anti-Htt antiserum to conﬁ  rm equal loading and the 
identity of the HD cell lines (see Results). (E) Knockdown of HAP40 protein levels in ﬁ  broblasts from all ﬁ  ve HD cell lines by RNAi. Western blot analysis of 
EEA1 and HAP40 in untransfected cells (lanes 1, 4, 7, 10, and 13), cells transfected with unrelated siRNA against GFP (lanes 2, 5, 8, 11, and 14), or 
HAP40 siRNA (lanes 3, 6, 9, 12, and 15). (F) EGFP-Rab5–labeled endosomes align primarily with microtubules in healthy ﬁ  broblasts. Primary human 
  ﬁ  broblasts from healthy individuals were transfected with EGFP-Rab5 (green) and ﬁ  xed and immunostained for microtubules and F-actin. The same cell is 
shown with its β-tubulin staining (red) on the left and for F-actin (red) on the right, as indicated. Arrowheads in the insets (magniﬁ  cations of the boxed areas) 
point to endosomes aligned with microtubules. Overlap of EGFP-Rab5 with tubulin signals was 82% (SD ± 9%, n = 10) for healthy ﬁ  broblasts and 15% 
(SD ± 6%, n = 9) for HD cell lines (see G). (G) The cell processed as in F shows that EGFP-Rab5–labeled endosomes align strikingly with F-actin in ﬁ  bro-
blasts from HD patients. Arrowheads in the insets point to endosomes (green) aligned with F-actin (red). Overlap of EGFP-Rab5 with actin was 2% (SD ± 1%, 
n = 10) for healthy ﬁ  broblasts (see F) and 44% (SD ± 8%, n = 10) for HD cell lines. Bar, 10 μm.THE HTT–HAP40 COMPLEX IS A NOVEL RAB5 EFFECTOR • PAL ET AL. 613
  phenotype was obtained by the overexpression of HAP40 in 
HeLa cells (not depicted).
The Htt–HAP40 complex enhances 
the binding of early endosomes to actin
The alignment of early endosomes on F-actin in HD cell lines 
could be a secondary effect from the inhibition of endosome–
microtubule interactions. To directly test the role of HAP40 in 
the association between early endosomes and actin fi  laments 
(Fig. 6, B and E), we modifi  ed the biochemical sedimentation 
assay used to study endosome–microtubule interactions (Fig. 6, 
A and D) by replacing taxol-stabilized microtubules with freshly 
in vitro–polymerized F-actin. Unlike for endosome–microtubule 
binding, depletion of active Rab5 from endosomal membranes 
by treatment with either Rab-GDI or RN-tre did not decrease 
endosome–actin interactions (Fig. 6 E). Thus, a basal level of 
endosome–F-actin binding activity was independent of Rab5. 
However, the addition of HAP40-GST fusion protein stimulated 
binding ( 260%) over control levels, whereas GST alone was 
ineffective. Evidently, endosome binding to microtubules and 
F-actin is reciprocally regulated through HAP40 because con-
centrations (1 μM) inhibiting binding to microtubules (Fig. 
6 D) clearly stimulated binding to F-actin (Fig. 6 E). This effect 
was Rab5 dependent because when Rab-GDI or RN-tre were 
added together with HAP40, the stimulation was nearly abol-
ished (Fig. 6 E). Again, immunoblotting confi  rmed that the 
amount of actin in the pellets was unaffected by any added pro-
tein and that all changes in pelletable fl  uorescence corresponded 
consistently to altered band intensities of early endosomal 
markers (EEA1 and TFr) but not to others (LAMP1 and GM130), 
indicating specifi  c effects of Htt–HAP40 on endosome–actin 
binding (Fig. 6 B).
Alterations in early endosome motility 
in a HD mouse model of striatal cells
Next, we investigated the role of HAP40 in Rab5 dynamics in an 
experimental system that is more relevant for HD using immor-
talized STHdhQ striatal cells (Trettel et al., 2000). These cells 
were established from embryonic normal or HD knock-in mice 
and either express normal (STHdhQ
7/7) or mutant Htt as a result 
of a CAG expansion inserted into the endogenous Htt gene (het-
erozygous STHdhQ
7/111 and homozygous STHdhQ
111/111). Thus, 
they refl  ect the closest situation to HD patients as normal, and 
mutant Htt are expressed at endogenous levels. Remarkably, 
we again found endogenous HAP40 protein levels elevated in 
STHdhQ
7/111 and STHdhQ
111/111 compared with STHdhQ
7/7 cells 
(Fig. 8 B), which is consistent with the data on HD fi  broblasts 
(Fig. 7 D) and brain tissue from HD patients (Fig. 8 B). Live cell 
imaging revealed EGFP-Rab5–positive organelles moving bidi-
rectionally in neuronlike outgrowths as well as in the cell body 
of normal STHdhQ
7/7 cells (Fig. 8 A and Video 6, available at 
http://www.jcb.org/cgi/content/full/jcb.200509091/DC1). Con-
versely, STHdhQ
111/111 and STHdhQ
7/111 cells clearly displayed 
a drastic reduction of endosome dynamics (Fig. 8 A and Videos
7 and 8), which is consistent with the observations on HD 
 fi broblasts (Fig. 7 B and Videos 3 and 4). Collectively, defects 
of Rab5 dynamics caused by pathogenic excess of HAP40 
  apparently occur in peripheral tissues such as fi  broblasts as well 
as in neuronal systems and, therefore, are of potential relevance 
for HD.
Increased HAP40 levels cause alterations 
in endocytic trafﬁ  cking
To gain some insights into possible alterations of endocytic 
transport caused by increased levels of HAP40, we tested the 
uptake of transferrin in HeLa cells overexpressing HAP40 and 
in fi  broblasts from healthy and HD patients. Fig. 10 A shows 
that the uptake of transferrin was reduced by 30% in HeLa cells 
overexpressing HAP40 compared with mock-transfected or 
control cells. Consistent with this result, fi  broblasts from HD 
patients displaying higher levels of endogenous HAP40 (Fig. 7 D) 
displayed a similarly reduced uptake of transferrin compared 
with normal fi  broblasts (Fig. 10 B). As for the block of endo-
some motility, the inhibitory effect on transferrin uptake was 
rescued by the depletion of HAP40 by RNAi. These data sug-
gest that the inhibitory effects on endosome motility caused by 
up-regulation of HAP40 also result in defects in cargo transport 
through the endocytic pathway.
Discussion
The key fi   nding of this study is that the complex between 
HAP40 and Htt is a direct downstream effector of Rab5 that 
regulates the dynamics of early endosomes through a switch 
from microtubules to F-actin. These fi  ndings provide important 
new insights into how the motility of early endosomes is regu-
lated under physiological and pathological conditions. Htt has 
been implicated in clathrin-mediated endocytosis, regulation of 
the actin cytoskeleton, and microtubule-dependent transport 
along the endocytic pathway via interactions with its numerous 
binding partners (Harjes and Wanker, 2003). Such multiplicity 
of roles implies that the activities of Htt in endocytic membrane 
traffi   cking need to be spatially and temporally coordinated. 
In showing for the fi  rst time that a complex between Htt and one 
of its binding partners, HAP40, can be recruited onto endo-
somes by interacting directly with Rab5, our data provide novel 
  insights into the mechanisms governing the targeting of Htt to 
early endosomes and its regulatory activity on cytoskeleton-
 dependent  dynamics.
Under normal physiological conditions, early endosomes 
undergo frequent short-range movements on actin but also 
long-range bidirectional movements along microtubules 
(Nielsen et al., 1999; Gasman et al., 2003; Rink et al. 2005). 
Plus end movement of early endosomes along microtubules is 
propelled by KIF16B (Hoepfner et al. 2005). Overexpression 
of HAP40, which is rate limiting for the recruitment of Htt 
on the membrane, caused the detachment of early endosomes 
from microtubules and their preferential association with actin 
fi   laments, thus limiting both their velocity and range of 
  movements. Therefore, the Htt–HAP40–Rab5 complex is a key 
  regulator of the switch from one type of fi  laments to another. 
Our data are consistent with previous studies documenting 
alterations in   microtubule-dependent motility in HD model 
systems (Block-Galarza et al., 1997; Engelender et al., 1997;JCB • VOLUME 172 • NUMBER 4 • 2006  614
Gauthier et al., 2004). However, these studies have exclusively 
implicated alterations between mutant Htt and HIP/HAP 
  effectors. For example, wild-type Htt has been shown to interact 
with the dynactin subunit p150
Glued via HAP1 and mutant Htt to 
disrupt the dynein motor complex in axonal transport (Gauthier 
et al., 2004). In this study, we have uncovered a different mech-
anism based on the up-regulation of an Htt adaptor, HAP40. 
Compelling evidence in support of this mechanism was pro-
vided by the rescue of the motility block upon depletion of 
HAP40 by RNAi both in HD fi  broblasts and in striatal cells. 
Because the COOH-terminal part of Htt is responsible for the 
underlying interactions with HAP40 and Rab5, this endosomal 
recruitment affects normal as well as mutant Htt. Consistently, 
wild-type (overexpression of HAP40 in HeLa cells), heterozy-
gous (STHdhQ
7/111), and homozygous (STHdhQ
111/111) HD cells 
display very similar phenotypes. In this way, functional compe-
tition with the Rab5-dependent endosomal kinesin KIF16B and 
disruption of the dynein–dynactin complex (Gauthier et al., 2004) 
could account for the compromised bidirectional microtubule-
based motility. Therefore, our data suggest that multiple defects 
may contribute to the block of vesicular transport in HD cells, 
which implicates various HIP/HAPs interacting with different 
regions of Htt.
Previous fi  ndings have shown that Htt is also linked to 
Rab8 through FIP-2 (Hattula and Peranen, 2000) and that this 
interaction regulates cell polarization and morphogenesis. 
Whereas the mechanism underlying the latter process is unclear, 
in light of our observation, we propose that Htt is a multifunc-
tional protein that may be recruited by different Rab GTPases 
through different adaptors at different intracellular locations to 
regulate organelle dynamics.
The primary pathological cause of HD is attributed to the 
abnormal activity of Htt and its interacting partners in the 
  nucleus (Landles and Bates, 2004). The majority of HAP40 is 
also nuclear under normal conditions (Fig. 3; Peters and Ross, 
2001), although the functional signifi  cance of this localization 
is unclear at present. Our data indicate that HAP40 fulfi  lls a 
function in the cytoplasm. It is interesting in this respect to note 
that HAP40 adds to the increasing list of proteins implicated 
in a dual role in endocytic traffi  cking and nuclear signaling 
  (Miaczynska et al., 2004). The molecular mechanism underly-
ing the up-regulation of HAP40 unexpectedly observed in cells 
and brain tissue from HD patients remains to be determined. 
The most likely explanation is that it arises as a consequence of 
alterations in gene expression caused by mutated Htt in the 
  nucleus. Messenger RNA microarray studies have revealed 
many transcriptional abnormalities in HD (Chan et al., 2002; 
Sipione et al., 2002; Sugars and Rubinsztein, 2003), although 
no changes for HAP40 or any other Htt-interacting partners 
have been reported so far. Up-regulation of HAP40 at the pro-
tein level might thus serve as a new diagnostic indicator for the 
disease. However, it is premature to judge to what extent this 
abnormality and the consequent alterations in membrane dy-
namics contribute to the pathogenetic mechanism of HD as 
compared with nuclear activities of Htt and HAP40. Although 
endosome motility is not perturbed in HD cells to the extent of 
compromising cell viability, we nevertheless uncovered defects 
in endocytic transport, specifi  cally a decrease in transferrin 
  uptake. These observations may be of particular functional rel-
evance in neurons given the importance of long-range transport 
(Block-Galarza et al., 1997; Engelender et al., 1997; Gauthier 
et al., 2004). Therefore, it is possible that alterations in endo-
some motility and transport may further compromise the patho-
logical state induced by mutated Htt on the survival and function 
of neurons or some selected populations of neurons where en-
dosomal transport is particularly rate limiting in vivo. Addressing 
Figure 8.  Elevated endogenous HAP40 pro-
tein levels impair Rab5 dynamics in vivo in 
STHdhQ
111/111 and STHdhQ
7/111 striatal cells 
from a HD mouse model. (A) Cells expressing 
normal (STHdhQ
7/7) or mutant (STHdhQ
111/111 
and STHdhQ
7/111) Htt were transfected with 
EGFP-Rab5 plasmid, differentiated, and im-
aged using time-lapse video microscopy. Over-
laid images were generated as described for 
Fig. 5 B. Videos corresponding to A are avail-
able as online supplemental material (Videos 
6–8, available at http://www.jcb.org/cgi/
content/full/jcb.200509091/DC1). Motility of 
Rab5 compartments was drastically reduced in 
STHdhQ
111/111 and STHdhQ
7/111 compared 
with STHdhQ
7/7 cells. Insets show magniﬁ  ca-
tions of boxed areas. Bar, 10 μm. (B) Endog-
enous protein levels of HAP40 are elevated in 
STHdhQ
111/111 (lane 1) and STHdhQ
7/111 (lane 2) 
compared with STHdhQ
7/7 cells (lane 3) 
as well as in striatal tissue from ﬁ  ve  human 
postmortem brains affected by HD (lanes 4–8) 
compared with healthy control brains (lanes 
9–13). Blots were also probed with anti-EEA1 
and anti-Htt antiserum to conﬁ  rm equal load-
ing and the expression of wild-type and mutant 
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this hypothesis requires a more thorough investigation of 
HAP40 and Htt function in the transport of different types of 
cargo along the endocytic/recycling as well as degradative 
pathway in neuronal cells rather than fi  broblasts. A deeper anal-
ysis of the role of HAP40 on the molecular level will hopefully 
improve our understanding of both HD pathogenesis and the 
mechanisms coordinating organelle–cytoskeleton interactions 
during membrane traffi  cking.
Materials and methods
Rab5 afﬁ  nity chromatography and HAP40 and Htt cloning
GST-Rab5 afﬁ  nity chromatography with bovine brain cytosol or in vitro–
translated proteins was performed as described previously (Christoforidis 
et al., 1999). HAP40 was cloned from rat brain cDNA by PCR, Htt frag-
ments were cloned by PCR on full-length Htt cDNA in pBlueScript (a gift 
from M. Sherman, Boston University School of Medicine, Boston, MA), 
and all PCR products were cloned into pcDNA3.1 (Invitrogen) and se-
quenced to conﬁ   rm their identity. To estimate the stoichiometry of the 
Figure 9.  Htt and HAP40 are recruited onto Rab5 vesicles in primary ﬁ  broblasts from human HD patients and STHdhQ
7/111 striatal cells from a HD mouse 
model. (A) Image gallery of the same ﬁ  broblast cell from a healthy individual transfected with EGFP-Rab5 (green) and ﬁ  xed and immunostained for endog-
enous HAP40 (red) and Htt (red). Boxed areas are magniﬁ  ed in the top panels. (B) The same analysis of a ﬁ  broblast from a HD patient. Yellow (arrowheads) 
indicates colocalization of EGFP-Rab5 and Htt (merge Rab5 and Htt,) or of EGFP-Rab5 and HAP40 (merge Rab5 and HAP40). Overlapping of EGFP-Rab5 
with Htt was 6% (SD ± 3%, n = 10) for ﬁ  broblasts from healthy individuals (A) and 46% (SD ± 8%, n = 10) from HD patients (B). Overlapping of EGFP-
Rab5 with HAP40 was 4% (SD ± 3%, n = 10) for ﬁ  broblasts from healthy individuals (A) and 51% (SD ± 9%, n = 10) from HD patients (B). (C) Image gal-
lery of the same differentiated STHdhQ
7/7 cell (homozygous for normal Htt) transfected with EGFP-Rab5 (green) and immunostained for endogenous HAP40 
(red) and Htt (red). (D) The same analysis of a differentiated STHdhQ
7/111 cell (heterozygous for mutant Htt). Overlapping of EGFP-Rab5 with Htt was 5% 
(SD ± 4%, n = 10) for STHdhQ
7/7 cells (C) and 83% (SD ± 12%, n = 10) for STHdhQ
7/111 cells (D). Overlapping of EGFP-Rab5 with HAP40 was 4% 
(SD ± 3%, n = 10) for STHdhQ
7/7 cells (C) and 86% (SD ± 15%, n = 10) for STHdhQ
7/111 cells (D). The analysis was restricted to cellular outgrowths. 
  Essentially the same results were obtained for STHdhQ
111/111 cells (homozygous for mutant Htt; not depicted). Bar, 10 μm.JCB • VOLUME 172 • NUMBER 4 • 2006  616
bound complex, GST-Rab5 was incubated in the presence of a 10-fold ex-
cess of the COOH-terminal fragment of Htt over HAP40. Band intensities 
obtained under these conditions were quantiﬁ   ed in ImageJ software 
  (National Institutes of Health; Htt4/HAP40 =  6:1) and corrected for the 
number of [
35S]methionine residues incorporated (Htt4/HAP40 = 22:4). 
The resulting ratio was  1:1. Assuming a 1:1 ratio of Rab protein to 
  effector, the stoichiometry of the Rab5/HAP40/Htt interaction was esti-
mated at  1:1:1.
Antibodies and recombinant proteins
Monoclonal mouse antibodies against Htt were obtained from Chemicon 
and Y. Trottier (Institut de Génétique et de Biologie Moléculaire et Cellu-
laire, Université Louis Pasteur, Illkirch, France), and polyclonal rabbit anti-
body against HAP40 was obtained from Chemicon. Microtubules were 
revealed with mouse monoclonal anti–β-tubulin antibody (BD Biosciences), 
and F-actin was revealed with AlexaFluor568-conjugated phalloidin (Invit-
rogen). Secondary anti–mouse and rabbit IgG for immunoﬂ  uorescence mi-
croscopy were conjugated to AlexaFluor568 and Cy5 (Invitrogen). Rabbit 
polyclonal anti-EEA1 antibody was described previously (Christoforidis 
et al. 1999), mouse monoclonal antibody against the cytoplasmic tail of Tfr 
was purchased from Invitrogen, mouse monoclonal anti-LAMP1 antibody 
was obtained from Becton Dickinson, and mouse monoclonal anti-GM130 
antibody was obtained from Abcam. Rab-GDI and RN-tre were prepared 
as described previously (Ullrich et al., 1994; Lanzetti et al., 2000). GST 
and HAP40-GST fusion proteins were afﬁ  nity puriﬁ  ed from Escherichia coli 
lysates according to standard procedures.
Cell culture procedures
HeLa and human primary ﬁ  broblast cells were grown according to stan-
dard procedures. Immortalized STHdhQ striatal cell lines from control and 
HD knock-in mice were cultured and differentiated as described previously 
(Trettel et al., 2000). For transient expression studies, cells were transfected 
using LipofectAMINE 2000 (Invitrogen) and used 12 h after transfection 
for immunoblot analysis or intracellular localization studies according to 
standard protocols. Fixed cells were analyzed using a 100×/NA 1.40 
plan-Apochromat oil immersion lens (Carl Zeiss MicroImaging, Inc.) on a 
microscope (Axiovert S100TV; Carl Zeiss MicroImaging, Inc.). Illumination 
was performed with a 100-W mercury lamp with ﬁ  lter sets for GFP, Alexa-
Fluor568, DAPI, and Cy5 ﬂ  uorescence. Images were acquired at 1,300 × 
1,000 pixels with a digital camera (SP 1.4.4; Diagnostic Instruments) con-
trolled by the MetaVue 6.1 software package (Universal Imaging Corp.). 
Raw images from various color channels were assembled and colorized in 
Adobe Photoshop 7.0. Brightness and contrast were adjusted for visual 
clarity. To validate immunoﬂ   uorescence microscopy studies using Alexa-
Fluor568- and Cy5-conjugated secondary antibodies, HAP40 was overex-
pressed in HeLa cells and cells stained with a mixture of anti-HAP40 and 
-Htt antisera. Single addition of secondary antibody against mouse IgG 
(for Htt) conjugated with AlexaFluor568 resulted in no detectable bleed-
through into the Cy5 channel at the exposure time and ﬁ  lter settings used 
for HAP40 detection with Cy5. Moreover, signals for HAP40 that were ob-
tained with Cy5 looked very similar in the presence or absence of Alexa-
Fluor568. Finally, when these dyes were swapped on the secondary 
antibodies, very similar distribution patterns for HAP40 and Htt were 
  obtained. Collectively, the colocalization between HAP40 and Htt revealed 
in Figs. 3 and 9 is not caused by bleed-through. The percentage of colocal-
ization between immunoﬂ  uorescence signals was determined as follows: 
raw signals from discrete membrane structures were manually counted and 
inspected for overlapping with signals in other channels to calculate the 
percentage of colocalization. Only signals above value 70 on the eight-bit 
tonal scale were considered speciﬁ  c and used for the analysis. Typically, 
10 cells (n  = 10) were counted to calculate the mean colocalization 
and SD. For overlapping studies of EGFP-labeled early endosomes with cy-
toskeletal ﬁ  laments, these organelles were considered colocalized to either 
microtubules or F-actin if at least three early endosomes in a row were 
clearly aligned to a ﬁ  lament. In areas where microtubules and F-actin con-
verged (e.g., close to the cell edge), early endosomes could often not be 
assigned to either type of ﬁ  lament. The sum of early endosomes aligned to 
microtubules, F-actin, and unassignable early endosomes (100%) was 
used to calculate percentages of colocalization. Internalized biotinylated 
transferrin was detected with ruthenium-labeled antitransferrin antibodies 
and subsequently quantiﬁ   ed by ECL analysis as described previously 
  (Hoepfner et al. 2005).
Cell lines and tissue samples
The primary human ﬁ  broblast cell lines GM00023, GM00024, GM00037, 
GM00038, and GM00041 (Apparently Healthy cell collection) and 
GM04281, GM04723, GM03621, GM04869, and GM04847 (Hun-
tington Disease cell collection) were obtained from Coriell Cell   Repositories. 
Cell lines were established from both genders from healthy, unrelated 
  individuals by the age of 3–31 yr or from clinically affected onset HD 
  patients by the age of 19–32 yr. Immortalized striatal cell lines established 
from mouse embryos (STHdhQ) were gifts from M. MacDonald (Richard B. 
Simches Research Center, Boston, MA; Trettel et al., 2000). Human 
  postmortem brain samples (CAP; Globus Pallidus) from healthy and HD 
grades 3 and 4 donors were provided by the Harvard Brain Tissue 
  Resource Center.
Protein identiﬁ  cation by mass spectrometry
Gel-separated Coomassie-stained proteins were excised from the gel slab 
and in-gel digested with trypsin as described previously (Shevchenko et al., 
1996). Tryptic peptides were sequenced by nanoelectrospray tandem 
mass spectrometry on hybrid quadrupole time-of-ﬂ  ight mass spectrometers 
(Q-TOF I; Micromass, Ltd. and QSTAR Pulsar I; MDS Sciex) as described 
previously (Shevchenko et al., 1997). Database searching was performed 
by Mascot software (Matrix Science, Ltd.).
In vitro motility of early endosomes
The in vitro motility assay was essentially performed as described previ-
ously (Nielsen et al., 1999) with the following modiﬁ  cations  (Hoepfner 
et al., 2005). KHMG (110 mM KCl, 50 mM Hepes-KOH, pH 7.4, 2 mM 
MgCl2, and 10% glycerol) was used as an assay buffer. For preparation 
of the antifade solution, BRB80 buffer was substituted with KHMG, and the 
Figure 10.  Elevated levels of HAP40 reduces transferrin uptake. (A) HeLa 
cells transfected with HAP40 expression (HAP40), empty plasmid (mock), 
or untreated (WT) were serum starved, allowed to internalize biotinylated 
transferrin (Tf) for the indicated times, washed, and lysed, and internalized 
transferrin was quantiﬁ  ed. The mean values of triplicate samples from one 
representative experiment out of three with SD (error bars, often omitted by 
plot symbols) are shown. (B) The same uptake for primary human ﬁ  bro-
blasts untreated or transfected with siRNA duplexes against HAP40 
  (siHAP40) or unrelated GFP (siGFP). The mean values of different cell lines 
from ﬁ  ve healthy persons (5× WT), ﬁ  ve HD patients (5× HD), the same but 
treated with siHAP40 (5× HD siHAP40), or the mean values of triplicate 
sample obtained from one HD line treated with unrelated siGFP (1× HD 
siGFP) are shown. Error bars (mostly omitted by plot symbols) represent the 
SD between cell lines (5× WT, 5× HD, and 5× HD siHAP40) or of tripli-
cate samples (1× HD siGFP).THE HTT–HAP40 COMPLEX IS A NOVEL RAB5 EFFECTOR • PAL ET AL. 617
solution was further supplemented with 10% serum. The energy mix con-
sisted of 75 mM creatine phosphate, 10 mM ATP, 10 mM GTP, and 20 mM 
MgCl2 in BRB80. For the assay, taxol-stabilized microtubules were per-
fused in a microscopy chamber and allowed to bind to the coverslip. Next, 
10 μl of 10% nonspeciﬁ  c rabbit serum in antifade solution was perfused in 
the chamber followed by 10 μl of the assay mixture (2 μl of 5 mg/ml ﬂ  uo-
rescently labeled early endosome, 1 μl of energy mix, 6 μl of the antifade 
solution, and 1 μl of saturated hemoglobin solution in KHMG) and was in-
cubated for 5 min at RT. At least three videos per sample were recorded 
(60 frames with 2-s intervals) and analyzed as described previously 
(Nielsen et al., 1999).
In vivo motility of early endosomes
Cells were grown on glass coverslips, transfected with EGFP-Rab5 alone 
or together with siRNA against HAP40, and transferred to custom-built 
aluminum microscope slide chambers (Nielsen et al., 1999) just before 
observation. Cells were analyzed in CO2-independent medium/10% 
FBS (Invitrogen) at 37°C using a 100×/NA 1.40 plan-Apochromat oil 
immersion lens (Carl Zeiss MicroImaging, Inc.) on a microscope (IX70; 
Olympus) placed in a temperature-controlled chamber. Illumination was 
performed with a 100-W Xenon lamp ﬁ   tted with a monochromator to 
excite GFP ﬂ  uorescence. Images were acquired at 512 × 512 pixels with 
a camera (Cascade 512B; Roper Scientiﬁ  c) in stream acquisition mode 
over 2 min in 300-ms intervals using the MetaVue 6.1 software pack-
age. Image stacks were either converted to QuickTime videos or motility 
events highlighted by generating Z projections of the entire stack using the 
  ImageJ software package.
Microtubule and actin spin-down assays
Binding of early endosomes to microtubules was performed as described 
previously (Nielsen et al., 1999) but with some modiﬁ  cations. 15 μg of 
prepared early endosomes pulsed with rhodamine–transferrin (Sigma-
  Aldrich) were incubated at RT with 5 μl of energy mix (see previous sec-
tion), 1 μl of nonspeciﬁ  c rabbit serum, and 1 μM of recombinant candidate 
factors (HAP40, Rab-GDI, or RN-tre) in KHMG buffer supplemented with 
1 mg/ml HeLa cell cytosol. After 20 min, 16 μg of taxol-stabilized microtu-
bules were added to a total volume of 50 μl. After 10 min more at RT, the 
reaction mixture was laid over 100 μl of a 35% (wt/vol) sucrose cushion. 
After sedimentation at 100,000 g for 20 min at 22°C in a rotor (TLA 100; 
Beckman Coulter), the supernatant was removed, and the resulting pellet 
was washed twice in cytosol-free KHMG buffer. The pellet was lysed in 
150 μl KHMG supplemented with 1% sodium deoxycholate, and the re-
leased rhodamine–transferrin was quantiﬁ   ed in a ﬂ  uorimeter.  Excitation 
was at 550 nm, and emission was at 582 nm. A calibration curve revealed 
a linear correlation between emission and early endosome concentration. 
The equation of the linear regression analysis was y = 4,548.4x − 
2,653.1 with R
2 = 0.9879, where y is the emission in arbitrary units and 
x is the concentration of early endosomes in protein mass units. For binding 
of early endosomes to F-actin, globular-actin (Cytoskeleton, Inc.) was po-
lymerized in KHMG buffer at RT for 1 h and centrifuged for 30 min at 
100,000 g. The resulting pellet was washed with KHMG buffer and resus-
pended at 10 mg/ml. The assay was then performed with 10 μg of F-actin 
as described for microtubules.
Online supplemental material
All videos show EGFP-Rab5 dynamics, and images were acquired as 
described in In vivo motility of early endosomes. Video 1 shows a wild-
type HeLa cell transfected with plasmid for EGFP-Rab5 expression only. 
Video 2 shows a HeLa cell cotransfected with plasmids for EGFP-Rab5 and 
HAP40. Video 3 shows a primary human ﬁ  broblast from a healthy person 
transfected with plasmid for EFGP-Rab5 expression only, whereas Video 4 
shows the ﬁ  broblast from a HD patient. Video 5 shows a primary human 
ﬁ   broblast from a HD patient cotransfected with plasmid for EGFP-Rab5 
transfection and siRNA duplexes against HAP40. Video 6 shows a striatal 
STHdhQ
7/7 cell transfected with plasmid for EGFP-Rab5 expression only, 
Video 7 shows the same for an STHdhQ
7/111 cell, and Video 8 shows this 
for an STHdhQ
111/111 cell. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200509091/DC1.
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